Home > Healthcare > Medical Devices > Diagnostic Devices > Transplant Diagnostics Market

Transplant Diagnostics Market Size

  • Report ID: GMI6035
  • Published Date: Jun 2023
  • Report Format: PDF

Transplant Diagnostics Market Size

Transplant Diagnostics Market was valued at around USD 5.8 billion in 2023 and is estimated to reach over USD 10.4 billion by 2032. The demand for organ transplantation continues to rise globally due to factors such as an aging population, increasing prevalence of chronic diseases, and advancements in transplant procedures. This creates a significant market opportunity for transplant diagnostics companies.

 

Advancements in technology have greatly improved the accuracy, speed, and efficiency of transplant diagnostics tests. For instance, the development of molecular testing techniques such as polymerase chain reaction (PCR) and next-generation sequencing (NGS) have revolutionized the field by enabling more precise and comprehensive analysis of genetic markers and compatibility factors. Non-invasive diagnostics methods are gaining popularity in transplant diagnostics that offer convenience, reduced risk, and the potential for real-time monitoring of graft health. The demand for transplant diagnostics products and services is expected to grow across different geographic regions as transplant procedures become more accessible worldwide. These variables present opportunities for companies to expand their market presence internationally.

 

Transplant diagnostics refers to the set of techniques and tests used to assess compatibility and monitor the status of organ and tissue transplants in recipients. It involves evaluating various factors to ensure the success of transplantation procedures including matching donor organs or tissues with the most suitable recipients, detecting potential complications or rejection, and monitoring the overall health and function of the transplanted organ or tissue.

 

However, the shortage of professionals with expertise in transplant diagnostics can lead to several problems. A lack of professionals may result in delays in performing transplant diagnostics that can prolong the waiting time for patients in need of organ transplants. This delay can have serious consequences for patients with life-threatening conditions. Insufficient expertise in this area can result in mismatched transplants, leading to higher rates of rejection and potential harm to patients.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market for transplant diagnostics was valued at around USD 5.8 billion in 2023 and will reach over USD 10.4 billion by 2032, owing to the rising demand for organ transplantation due to factors such as an aging population, increasing prevalence of chronic diseases, and advancements in transplant procedures.

The reagents segment was valued at over USD 3.2 billion in 2022. This segmental share is driven by the rising demand for personalized medicine, as well as the reagents’ ability to detect the compatibility or incompatibility between the donor and recipient.

North America transplant diagnostics market size will expand considerably during 2023 and 2032, due to the advanced healthcare infrastructure in the region, high demand for organ transplants, and rising awareness about the benefits of organ transplantation.

Abbott Laboratories, Becton, Dickinson and Company, BioGenuix, Biomérieux SA, Bio-Rad Laboratories Inc.

Transplant Diagnostics Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 17
  • Tables & Figures: 527
  • Countries covered: 31
  • Pages: 180
 Download Free Sample